Phenobarbitone prophylaxis for neonatal hyperbilirubinemia
CY Yeung, LS Tam, A Chan, KH Lee - Pediatrics, 1971 - publications.aap.org
In a controlled study of phenobarbitone prophylaxis for neonatal hyperbilirubinemia, 133
term infants born of group O mothers were divided into three study groups. The first
consisted of 45 control infants receiving no medication, the second of 44 infants born of
mothers who received 30 mg of the drug every night for an average of 2 weeks before
delivery, and the third of 44 infants given phenobarbitone 5 mg 8-hourly for an average of
3½ days beginning 6 to 8 hours after birth. The serum bilirubin of all infants was assessed …
term infants born of group O mothers were divided into three study groups. The first
consisted of 45 control infants receiving no medication, the second of 44 infants born of
mothers who received 30 mg of the drug every night for an average of 2 weeks before
delivery, and the third of 44 infants given phenobarbitone 5 mg 8-hourly for an average of
3½ days beginning 6 to 8 hours after birth. The serum bilirubin of all infants was assessed …